Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Treatment With Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants: Comparison of High and Low Dose

NCT00910234 is registered in ClinicalTrials.gov with China Medical University Hospital as lead sponsor.

NCT NCT00910234
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910234 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Treatment With Recombinant Erythropoietin for Neuroprotection in Very Preterm Infants: Comparison of High and Low Dose
Lead sponsor
China Medical University Hospital
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 31, 2009
Completion date
July 31, 2011
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infant, premature, intraventricular hemorrhage, leukomalacia, periventricular, retinopathy of prematurity